"Pharmaxis Limited - Product Pipeline Review - 2012" is now available at Fast Market Research

2012-10-10 09:22:57 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Market Direct's pharmaceuticals report, "Pharmaxis Limited - Product Pipeline Review - 2012" provides data on the Pharmaxis Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Pharmaxis Limited's corporate website, SEC filings, investor presentations and featured press releases, both from Pharmaxis Limited and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Pharmaxis Limited - Brief Pharmaxis Limited overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Pharmaxis Limited human therapeutic division.
*

Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Pharmaxis Limited with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Pharmaxis Limited's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Full Report Details at
- www.fastmr.com/prod/468581_pharmaxis_limited_product_pipeline_re ..

Reasons to buy

* Evaluate Pharmaxis Limited's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Pharmaxis Limited in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Pharmaxis Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Pharmaxis Limited.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Pharmaxis Limited and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Pharmaxis Limited Snapshot
Pharmaxis Limited Overview
Key Information
Key Facts
Pharmaxis Limited - Research and Development Overview
Key Therapeutic Areas
Pharmaxis Limited - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pharmaxis Limited - Pipeline Products Glance
Pharmaxis Limited - Late Stage Pipeline
Registration Filed Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Pharmaxis Limited Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Pharmaxis Limited - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Pharmaxis Limited - Drug Profiles
ASM-8
Product Description
Mechanism of Action
R&D Progress
mannitol
Product Description
Mechanism of Action
R&D Progress
PXS TPI-1100
Product Description
Mechanism of Action
R&D Progress
PXS-25
Product Description
Mechanism of Action
R&D Progress
PXS-4159
Product Description
Mechanism of Action
R&D Progress
PXS-4206
Product Description
Mechanism of Action
R&D Progress
Pharmaxis Limited - Pipeline Products by Route of Administration
Pharmaxis Limited - Pipeline Products By Mechanism of Action
Pharmaxis Limited - Recent Pipeline Updates
Pharmaxis Limited - Dormant Projects
Pharmaxis Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Pharmaxis Limited, Recent Developments
Pharmaxis Limited- Press Release
Aug 02, 2012: FDA Accepts Pharmaxis's Bronchitol New Drug Application For Review
Aug 01, 2012: Pharmaxis's Bronchitol Listed On Pharmaceutical Benefits Scheme For Treatment Of Cystic Fibrosis
Jun 08, 2012: Pharmaxis's Bronchitol Reduces Risk Of Exacerbations In Patients With Cystic Fibrosis
May 31, 2012: NICE Turns Down Pharmaxis's Bronchitol For Treatment Of Cystic Fibrosis
May 21, 2012: Pharmaxis Submits US New Drug Application For Bronchitol
Apr 20, 2012: Pharmaxis Receives Approval To Market Bronchitol In EU
Apr 17, 2012: Pharmaxis Completes Phase II Clinical Study With ASM8 In Asthma Patients
Apr 16, 2012: Pharmaxis Provides European Regulatory Update On Bronchitol
Mar 14, 2012: Pharmaxis's Bronchitol To Be Reimbursed In Australia
Jan 03, 2012: Pharmaxis Receives J-Code From Centers For Medicare And Medicaid Services For ARIDOL
Dec 29, 2009: Pharmaxis Receives Complete Response Letter From The USFDA On Aridol Application
Dec 29, 2009: Pharmaxis receives response letter from the FDA on Aridol application
Nov 23, 2009: FDA Advisory Committee Recommends Approval of Pharmaxis' Aridol
Nov 03, 2009: Pharmaxis Appoints French Distributor For Aridol
May 14, 2009: U.S. FDA Accepts Aridol New Drug Application For Review
May 04, 2009: Pharmaxis Announces Positive Results Of Phase 3 Cystic Fibrosis Trial
Feb 03, 2009: Pharmaxis Announces New Drug Application Submission For Aridol
Jan 12, 2009: TOPIGEN Pharmaceuticals Reports Phase 2 Results Of TPI ASM8 In Asthma Patients
Financial Deals Landscape
Pharmaxis Limited, Deals Summary

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468581&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.